45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
25,920
Insurances with rates
8
CPT / HCPCS codes
17,729
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 146242 | TREMELIMUMAB-ACTL 20 MG/ML IV SOLN | $185,323 | $107,487 | — | — | 0 |
| 95543 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) IV SOLN | $159,001 | $92,221 | — | — | 0 |
| 139387 | RAVULIZUMAB-CWVZ 100 MG/ML IV SOLN | $107,248 | $62,204 | — | — | 0 |
| 145692 | SPESOLIMAB-SBZO 60 MG/ML IV SOLN | $89,604 | $51,970 | — | — | 0 |
| 910073 | POLATUZUMAB VEDOTIN-PIIQ 140 MG/7 ML IV (WET SOLR VIAL) | $83,338 | $48,336 | — | — | 0 |
| 89831 | USTEKINUMAB 90 MG/ML SUBQ SYRG | $81,004 | $46,982 | — | — | 0 |
| 148533 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBQ SOLN | $73,795 | $42,801 | — | — | 0 |
| 148956 | EFGARTIGIMOD-HYALURONIDAS-QVFC 1,008 MG-11,200 UNIT/5.6 ML SUBQ SOLN | $72,041 | $41,784 | — | — | 0 |
| 125215 | OCRELIZUMAB 30 MG/ML IV SOLN | $70,931 | $41,140 | — | — | 0 |
| 124841 | CANAKINUMAB (PF) 150 MG/ML SUBQ SOLN | $69,491 | $40,305 | — | — | 0 |
| 143919 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20 ML IV SOLN | $67,702 | $39,267 | — | — | 0 |
| 910104 | TARLATAMAB-DLLE 10 MG/4.2 ML IV (WET SOLR VIAL) | $67,167 | $38,957 | — | — | 0 |
| 910020 | CABAZITAXEL 60 MG/6 ML IV (AFTER FIRST DILUTION) (WET SOLN VIAL) | $64,295 | $37,291 | — | — | 0 |
| 137024 | PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 1,200 MG-600MG- 30000 UNIT/15ML SUBQ SOLN | $62,315 | $36,143 | — | — | 0 |
| 149456 | ELRANATAMAB-BCMM 40 MG/ML SUBQ SOLN | $61,628 | $35,744 | — | — | 0 |
| 910019 | BRENTUXIMAB VEDOTIN 50 MG/10 ML IV (WET SOLR VIAL) | $54,629 | $31,685 | — | — | 0 |
| 122112 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) IV SOLN | $51,895 | $30,099 | — | — | 0 |
| 137484 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $51,214 | $29,704 | — | — | 0 |
| 141105 | DOSTARLIMAB-GXLY 50 MG/ML IV SOLN | $50,762 | $29,442 | — | — | 0 |
| 138314 | DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBQ SOLN | $47,102 | $27,319 | — | — | 0 |
| 132710 | CEMIPLIMAB-RWLC 50 MG/ML IV SOLN | $43,030 | $24,957 | — | — | 0 |
| 146246 | TECLISTAMAB-CQYV 90 MG/ML SUBQ SOLN | $42,421 | $24,604 | — | — | 0 |
| 136358 | LUSPATERCEPT-AAMT 75 MG SUBQ SOLR | $41,589 | $24,122 | — | — | 0 |
| 137025 | PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 600 MG-600 MG- 20000 UNIT/10ML SUBQ SOLN | $41,542 | $24,094 | — | — | 0 |
| 95542 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) IV SOLN | $39,750 | $23,055 | — | — | 0 |
| 146891 | UBLITUXIMAB-XIIY 25 MG/ML IV SOLN | $38,198 | $22,155 | — | — | 0 |
| 57001687 | SPECTRA WAIVEWRITER IPG KIT | $37,577 | $21,795 | — | — | 0 |
| 133993 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) IV SOLN | $36,326 | $21,069 | — | — | 0 |
| 910058 | LURBINECTEDIN 4 MG/8.5 ML IV (WET SOLR VIAL) | $36,315 | $21,063 | — | — | 0 |
| 129888 | NIVOLUMAB 240 MG/24 ML IV SOLN | $34,870 | $20,225 | — | — | 0 |
| 126234 | RITUXIMAB-HYALURONIDASE,HUMAN 1600 MG/13.4 ML (120 MG/ML) SUBQ SOLN | $33,656 | $19,520 | — | — | 0 |
| 138223 | ROMIDEPSIN 5 MG/ML IV SOLN | $32,684 | $18,957 | — | — | 0 |
| 111635 | VEDOLIZUMAB 300 MG IV SOLR | $32,188 | $18,669 | — | — | 0 |
| 102454 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) IV SOLN | $30,541 | $17,714 | — | — | 0 |
| 57002724 | CARDIOVERTER DEFIBRILLATOR DUAL CHAMBER | $29,786 | $17,276 | — | — | 0 |
| 146545 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML IV SOLN | $29,702 | $17,227 | — | — | 0 |
| 126152 | RITUXIMAB-HYALURONIDASE,HUMAN 1400 MG/11.7 ML (120 MG/ML) SUBQ SOLN | $29,449 | $17,080 | — | — | 0 |
| 109572 | OBINUTUZUMAB 1,000 MG/40 ML IV SOLN | $29,334 | $17,014 | — | — | 0 |
| 75761 | ECULIZUMAB 300 MG/30 ML IV SOLN | $29,209 | $16,941 | — | — | 0 |
| 910007 | ADO-TRASTUZUMAB EMTANSINE 160 MG/8 ML IV (WET SOLR VIAL) | $28,584 | $16,578 | — | — | 0 |
| 25021193 | PYELOPLASTY, ROBOT-ASSISTED, LAPAROSCOPIC, USING DA VINCI XI, ADULT | $27,972 | $16,224 | — | — | 0 |
| 25023062 | COLOSTOMY CREATION,ADVANCED LAPAROSCOPIC | $27,972 | $16,224 | — | — | 0 |
| 10019 | ALTEPLASE 100 MG IV SOLR | $27,775 | $16,110 | — | — | 0 |
| 421254 | ALTEPLASE 100 MG IV SOLR | $27,775 | $16,110 | — | — | 0 |
| 421256 | ALTEPLASE 100 MG IV SOLR | $27,775 | $16,110 | — | — | 0 |
| 910113 | ALTEPLASE 100 MG IV SOLR | $27,775 | $16,110 | — | — | 0 |
| 130781 | TENECTEPLASE 50 MG IV SOLR | $27,683 | $16,056 | — | — | 0 |
| 115922 | PEMBROLIZUMAB 25 MG/ML IV SOLN | $26,409 | $15,317 | — | — | 0 |
| 25021162 | PROSTATECTOMY, RETROPUBIC, RADICAL, ROBOT-ASSISTED, WITH LYMPHADENECTOMY, LAPAROSCOPIC, USING DA VIN | $25,136 | $14,579 | — | — | 0 |
| 910056 | IXABEPILONE 45 MG/22.5 ML IV (WET SOLR VIAL) | $24,797 | $14,382 | — | — | 0 |
Showing top 50 of 25,920 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.